Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.60 and traded as high as $7.89. AIkido Pharma shares last traded at $6.74, with a volume of 599,240 shares traded.
AIkido Pharma Price Performance
The business has a 50-day moving average of $4.15 and a 200-day moving average of $2.60. The firm has a market cap of $36.97 million, a price-to-earnings ratio of -1.74 and a beta of 0.93.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Read More
- Five stocks we like better than AIkido Pharma
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Investing in Travel Stocks Benefits
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
